1. Araki H, Li Y, Yamamoto Y, Haneda M, Nishi K, Kikkawa R and Ohkubo I, 2001, Purification, molecular cloning, and immunohistochemical localization of dipeptidyl peptidase II from the rat kidney and its identity with quiescent cell proline dipeptidase. J. Biochem. (Tokyo) 129: 279–288.
2. Auget M, Delaflotte S, Chabrier EP and Braquet P, 1989, Comparative effects of endothelin and phorbol 12–13 dibutyrate. Life Sci. 45: 2051–2059.
3. Augustyns K, Bal G, Thonus G, Belyaev A, Zhang XM, Bollaert W, Lambeir AM, Durinx C, Goossens F, Haemers A, 1999, The unique properties of dipeptidyl-peptidase IV (DPP IV/CD26) and the therapeutic potential of DPP IV inhibitors. Curr Med Chem. 6: 311–327.
4. Billah MM, Chapman RW, Egan RW, Gilchrest H, Piwinski JJ, Sherwood J, Siegel MI, West RE Jr, Kreutner W, 1990, Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine. J Pharmacol Exp Ther. 252: 1090–1096.
5. Black JW, Duncan WA, Durant CJ, Ganellin CR, Parsons EM, 1972, Definition and antagonism of histamine H2-receptors. Nature 236: 385–390.